1. Gene-modified dendritic cell vaccines for cancer
    Rebecca S. Abraham et al, 2016, Cytotherapy CrossRef
  2. Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies
    Annelisa M. Cornel et al, 2018, Frontiers in Immunology CrossRef
  3. Suppressor of Cytokine Signaling (SOCS) Genes Are Silenced by DNA Hypermethylation and Histone Deacetylation and Regulate Response to Radiotherapy in Cervical Cancer Cells
    Moon-Hong Kim et al, 2015, PLOS ONE CrossRef
  4. Combining MPDL3280A with adoptive cell immunotherapy exerts better antitumor effects against cervical cancer
    Yi Zheng et al, 2017, Bioengineered CrossRef
  5. High expression of octamer transcription factor 1 in cervical cancer
    SONGSHU XIAO et al, 2014, Oncology Letters CrossRef
  6. Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus
    Maryam Dadar et al, 2018, Frontiers in Immunology CrossRef
  7. Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins
    Sarah M. McCormick et al, 2015, Frontiers in Immunology CrossRef
  8. Cancer Immunotherapy: Silencing Intracellular Negative Immune Regulators of Dendritic Cells
    Yao-Hua Liu et al, 2019, Cancers CrossRef
  9. Advancing Immunotherapies for HPV-Related Cancers: Exploring Novel Vaccine Strategies and the Influence of Tumor Microenvironment
    Anna Jéssica Duarte Silva et al, 2023, Vaccines CrossRef
  10. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
    Sung-Jong Lee et al, 2016, Journal of Gynecologic Oncology CrossRef
  11. The Immunotherapeutic Effect of SIRPα-Silenced DCs against Cervical Cancer
    Xiaojie Li et al, 2020, Journal of Immunology Research CrossRef
  12. Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models
    Yi Zheng et al, 2017, Cytotherapy CrossRef
  13. Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
    Chunlei Ge et al, 2017, BMC Cancer CrossRef
  14. The Antitumor Activity of CAR-T-PD1 Cells Enhanced by HPV16mE7-Pulsed and SOCS1-Silenced DCs in Cervical Cancer Models
    Jingwei Zheng et al, 2021, Cancer Management and Research CrossRef